SCHEMBL8190077

SCHEMBL8190077

OCC=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.41
HSP90AA1 P07900 1/20 0.39
CFTR P13569 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA5A P35218 1/20 0.39
TSHR P16473 4/20 0.38
ALOX15 P16050 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
ALPG P10696 1/20 0.33
ALOX12 P18054 1/20 0.33
NPY1R P25929 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7523648 0.83 GAA (0.45) GAAHSP90AA1CFTRCA2CA4
SCHEMBL808442 0.77 MEN1 (0.39) GAAHSP90AA1CFTRCA2CA4
Bromide SCHEMBL28241411 0.75 MEN1 (0.38) GAAHSP90AA1CFTRCA2CA4
SCHEMBL27661786 0.75 MEN1 (0.38) GAAHSP90AA1CFTRCA2CA4
SCHEMBL10665143 0.75 HSP90AA1 (0.35) GAAHSP90AA1CFTRCA2CA4
SCHEMBL7096547 0.75 ALDH1A1 (0.36) GAAHSP90AA1CFTRCA2CA4
SCHEMBL3115111 0.75 USP2 (0.47) GAAHSP90AA1CFTRCA2CA4
SCHEMBL27728842 0.75 HSP90AA1 (0.44) GAAHSP90AA1CFTRCA2CA4
SCHEMBL808497 0.73 MEN1 (0.41) GAAHSP90AA1TSHRALDH1A1MEN1
Bromide SCHEMBL11501984 0.73 ALDH1A1 (0.35) GAAHSP90AA1CFTRCA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230663-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE ALEMBIC LIMITED (IN) 2011-09-22 US disclosed
US-6043270-A ANTIINFLAMMATORY AGENTS PROCYON PHARMACEUTICALS, INC. (US) 2000-03-28 US disclosed
US-5962498-A Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity PROCYON PHARMACEUTICALS, INC. (US) 1999-10-05 US disclosed
EP-0553107-B1 PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY PROCYON PHARM INC (US) 1999-09-29 EP disclosed
US-5955501-A DERIVED FROM PHORBOIDS OF THE DITERPENE- AND BENZOLACTAM-CLASSES. PROCYON PHARMACEUTICALS, INC. (US) 1999-09-21 US disclosed
US-5891870-A ANTIINFLAMMATORY AGENTS USING BENZODITERPENES AND BENZOLACTAMS PROCYON PHARMACEUTICALS, INC. (US) 1999-04-06 US disclosed
US-5891906-A Polyacetate-derived phorboids having anti-inflammatory and other uses PROCYON PHARMACEUTICALS, INC. (US) 1999-04-06 US disclosed
US-5886017-A Protein kinase C modulators. E. PROCYON PHARMACEUTICALS, INC. (US) 1999-03-23 US disclosed
US-5886019-A REPLACEMENT OF HYDROXYMETHYL OR-ETHYL GROUP ON TRICYCLIC AROMATIC HETEROCYCLIC COMPOUNDS HAVING INDOLE, INDENE, BENZOFURAN OR BENZOTHIOPHENE SKELETON; ANTIINFLAMMATORY, ANTIVIRAL PROCYON PHARMACEUTICALS, INC. (US) 1999-03-23 US disclosed
US-5750568-A DITERPENE PHORBOIDS PROCYON PHARMACEUTICALS, INC. (US) 1998-05-12 US disclosed
US-5716968-A ANTIINFLAMMATORY AGENTS; VIRICIDE PROCYON PHARMACEUTICALS, INC. (US) 1998-02-10 US disclosed
EP-0455271-B1 Anti-inflammatory compositions PROCYON PHARM INC (US) 1997-08-20 EP disclosed
US-5643948-A ANTIINFLAMMATORY, ANTICANCER PROCYON PHARMACEUTICALS, INC. (US) 1997-07-01 US disclosed
US-5145842-A Protein kinase c. modulators. d. ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) 1992-09-08 US disclosed
WO-1992002484-A1 PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) 1992-02-20 WO disclosed
US-5068325-A Dopaminergic systems as hypotensives, sedatives, antitussives and/or antiphlogistics KARL THOMAE GMBH (DE) 1991-11-26 US disclosed
EP-0455271-A2 Anti-inflammatory compositions PROCYON PHARMACEUTICALS, INC. (US) 1991-11-06 EP disclosed
EP-0310622-A1 ANTI-INFLAMMATORY COMPOSITIONS. ALDER RES CENTER CORP (US) 1989-04-12 EP disclosed
WO-1987007599-A2 ANTI-INFLAMMATORY COMPOSITIONS ALDER RESEARCH CENTER CORPORATION (US) 1987-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230663-A1 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE BCHE, ACHE, PSEN1 GAA 157/4885HSP90AA1 4317/4885CFTR 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.